Netris pancreatic cancer study doses first patient
Company’s candidate NP137 combined with mFOLFIRINOX will be researched during vital trials
Read More
Tag: Netris
Netris Pharma starts hepatocellular carcinoma study
Trial will evaluate efficacy of anti-netrin-1 antibody candidate NP137 in combination with Atezo-bev
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
